A Florida scientist says sponsors and care providers need to recruit Parkinson’s sufferers as soon as they are diagnosed with mild motor features, before they require meds. Recent discoveries have given researchers hope that they are on a path toward effective treatments, but that won’t happen unless we have enough patients for clinical trials at the earliest stages of the disease. Currently, less than 3 percent of Parkinson’s patients enroll in clinical trials. (CenterWatch)